Since its founding in 1996, IAVI has evolved from an advocacy organization primarily focused on making AIDS vaccine development a priority on the global public health agenda to become a full-scale research, advocacy and policy organization, capable of contributing to every phase of AIDS vaccine development. Learn more about our history.
The Board of Directors is the governing body of IAVI, responsible for overseeing the organization’s management and strategic direction. Directors bring to IAVI a wide range of expertise, including experience in government, industry, private foundations and non-governmental organizations.
A chief executive officer leads the organization and serves as an ex-officio member of the Board. Committees of the board oversee individual aspects of governance. They include:
- The Audit & Finance Committee, which ensures the integrity and reliability of IAVI’s financial reporting and the organization’s management of risk, as well as being responsible for the independent verification and oversight of whistleblower reports
- The Nominating Committee of the Board nominates new Board members and evaluates the service of current directors
- The Compensation Committee reviews overall compensation for the organization, including that of the CEO
- The Scientific Advisory Committee and Policy Advisory Committee provide senior leaders and the Board of Directors with strategic advice on IAVI’s research and policy programs.
Members of the IAVI Board of Directors are not paid any remuneration for their services. Only expenses incurred in the performance of their duties as director may, within reasonable limits, be reimbursed.
IAVI’s senior leaders—responsible for day-to-day operations and for executing the overall organizational strategy—are a diverse group of individuals with expertise in a range of areas, including vaccine research and global health policy and advocacy.